Yokukansan alleviates cancer pain by suppressing matrix metalloproteinase-9 in a mouse bone metastasis model

6Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Bone cancer pain control is difficult because it includes various characteristics of pain such as nociceptic and neuropathic pain. In this study, we investigated the effect of yokukansan (YKS), one of the traditional Japanese herbal medicines, on cancer pain in mouse bone metastasis model. Oral administration of YKS significantly alleviated pain behavior measured by quantitative body weight bearing. Furthermore, the pain behavior was also significantly alleviated by intrathecal and intraperitoneal administration of matrix metalloproteinase- (MMP-) 9 inhibitor, but not of MMP-2 inhibitor. MMP-9 expression was significantly elevated in the bone tissue on day 3 after carcinoma cell injection and in the ipsilateral spinal cord on day 7, which was suppressed by YKS administration. Taken together, these results suggest that YKS alleviates cancer pain via suppressing MMP-9 expression in bone metastasis model in mice.

Cite

CITATION STYLE

APA

Nakao, K., Fujiwara, A., Komasawa, N., Jin, D., Kitano, M., Matsunami, S., … Minami, T. (2019). Yokukansan alleviates cancer pain by suppressing matrix metalloproteinase-9 in a mouse bone metastasis model. Evidence-Based Complementary and Alternative Medicine, 2019. https://doi.org/10.1155/2019/2956920

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free